Raptor Pharm (RPTP) Posts Q1 Loss of 20c/Share

Raptor Pharm (NASDAQ: RPTP) reported Q1 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $11.81 million.

For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
• SuperCom (SPCB) Tops Q3 EPS by 43c